Felix Kaul
Impact in
Papers in
- Oncology 10
- Lung Cancer Research Studies 5
- Pancreatic and Hepatic Oncology Research 2
- Epidemiology 10
- Neuroendocrine Tumor Research Advances 10
- Co-authors
- Jürgen A. Kleinschmidt (2 shared papers)Martin Trepel (2 shared papers)Oliver J. Müller (2 shared papers)Damian Wild (13 shared papers)Matthew D. Weitzman (1 shared paper)Wadih Arap (1 shared paper)Renata Pasqualini (1 shared paper)Melpomeni Fani (9 shared papers)
- Journals
- Journal of Nuclear Medicine (3 papers)European Journal of Nuclear Medicine and Molecular Imaging (2 papers)EJNMMI Research (2 papers)Frontiers in Oncology (1 paper)Journal of Hepato-Biliary-Pancreatic Sciences (1 paper)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Felix Kaul
18 papers receiving 968 citations
Peers
Comparison fields: 5 of 65
- Oncology 464
- Neurology 234
- Epidemiology 456
- Radiology, Nuclear Medicine and Imaging 248
- Genetics 298
Countries citing papers authored by Felix Kaul
This map shows the geographic impact of Felix Kaul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felix Kaul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felix Kaul more than expected).
Fields of papers citing papers by Felix Kaul
This network shows the impact of papers produced by Felix Kaul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felix Kaul. The network helps show where Felix Kaul may publish in the future.
Co-authors
The 25 scholars most cited alongside Felix Kaul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 317 | |
| 2 | 2014 | 196 | |
| 3 | 2017 | 129 | |
| 4 | 2018 | 97 | |
| 5 | 2019 | 67 | |
| 6 | 2010 | 67 | |
| 7 | 2007 | 54 | |
| 8 | 2020 | 15 | |
| 9 | 2021 | 9 | |
| 10 | 2024 | 6 | |
| 11 | PET/CT with the somatostatin receptor antagonist 68Ga-OPS202 is twice as accurate as with the agonist 68Ga-DOTATOC for detecting liver metastases: Results of a phase 1/2 study in gastroenteropancreatic NET patients. | 2016 | 5 |
| 12 | 2021 | 5 | |
| 13 | 2021 | 4 | |
| 14 | 2019 | 3 | |
| 15 | First clinical data on 68Ga-labeled somatostatin receptor antagonists: a phase I/II study comparing 68Ga-OPS202 with 68Ga-DOTATOC PET/CT. | 2015 | 3 |
| 16 | 2021 | 2 | |
| 17 | 2023 | 1 | |
| 18 | Pitfalls in the Detection of Insulinomas with GLP-1R Imaging | 2020 | 1 |
| 19 | 2025 | 0 | |
| 20 | 2023 | 0 |
About Felix Kaul
Felix Kaul is a scholar working on Oncology, Epidemiology, Radiology, Nuclear Medicine and Imaging, Neurology and Endocrinology, Diabetes and Metabolism, having authored 20 papers that have together received 981 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (10 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Lung Cancer Research Studies (5 papers), Neuroblastoma Research and Treatments (4 papers), Virus-based gene therapy research (2 papers), Gastrointestinal Tumor Research and Treatment (2 papers), Pancreatic and Hepatic Oncology Research (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Oncology (464 citations), Neurology (234 citations), Epidemiology (456 citations), Radiology, Nuclear Medicine and Imaging (248 citations) and Genetics (298 citations). Felix Kaul has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Jürgen A. Kleinschmidt, Martin Trepel, Oliver J. Müller, Damian Wild, Matthew D. Weitzman, Wadih Arap, Renata Pasqualini, Melpomeni Fani, Guillaume Nicolas and Emanuel Christ. Their work appears in journals such as Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging, EJNMMI Research, Frontiers in Oncology and Journal of Hepato-Biliary-Pancreatic Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.